Cresp Injection

Product Details:

Click to View more
Share Your Product:

Request to Call Back Send Inquiry

Product Description

We have carved a niche by offering our clients superior quality Cresp that is world's first and India's only generic version of darbepoetin alpha. Offered medicine is used for the treatment of anemia caused by the renal transplants and other HIV conditions. Precisely formulated as per medical industry norms using quality-approved basic chemicals, this medicine is available with us in several packaging options to meet the diverse demands of the clients. Clients can avail this Cresp at market leading prices from us within committed time frame.

Features:

Precise composition
Accurate pH value
Purity
High effectiveness

We trade, supply, distribute and export Cresp to our esteemed clients. It is world's first and India's only generic version of darbepoetin alpha. It is used to treat anemia (from renal transplants or certain HIV treatment). Cresp helps in reduced frequency of doses providing a convenient treatment option for physicians and patients. It is highly effective and hence is widely appreciated by clients in domestic and international markets. It is available at highly reasonable prices in the market.

Cresp (darbepoetin alfa) injection is a physician endorsed medicate used to treat paleness because of perpetual kidney infection or because of chemotherapy. Cresp 40mcg infusion is an erythropoiesis-empowering operator (esa). It stimulates bone marrow to create more red platelets.

Producer : dr reddy's laboratories ltd.

Additional information :

Dosage available : 25mcg, 40mcg, 60mcg, 100mcg and 200mcg
Storage : store at temperature between 2^oC - 8^oC

Dosages :

Renal anemia: hemodialysis patients :

The standard dosage of cresp in grown-up patients is 20 g as cresp (genetical recombination), to be regulated as a solitary intravenous infusion once week after week.

Peritoneal dialysis patients and patients with chronic kidney disease not on dialysis:

The standard dosage of cresp in grown-up patients is 30 g as cresp (genetical recombination), to be controlled as a solitary infusion once like clockwork subcutaneously or intravenously.

Treatment of anemia in cancer patients receiving myelosuppressive chemotherapy:

Start cresp in patients on disease chemotherapy just if the hemoglobin is under 10 g/dl, and if there is at least two extra long stretches of arranged chemotherapy.

Reactions :